---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-237195"
form_type: "8-K"
ticker: "JAGX"
cik: "0001585608"
company_name: "Jaguar Health, Inc."
filed_at: "2026-05-22T21:22:44+00:00"
generated_at: "2026-05-22T21:29:51.435816+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Jaguar Health issues 54k shares to Streeterville in exchange for Series Q preferred; adjourns annual meeting to June 2

## Summary
- Issued 54,222 common shares to Streeterville in exchange for 7.96 shares of Series Q Preferred Stock.
- Common shares to be issued without restrictive legend; Streeterville can resell under Rule 144 using tacked holding period from Aug 2022.
- Annual Meeting adjourned to June 2, 2026; supplement to proxy to be filed after discussions with Nasdaq staff.
- Company plans to provide additional information to stockholders regarding certain proposals in the proxy statement.
- Record date remains April 15, 2026 for the reconvened meeting.

## SEC filing metadata
- accession: 0001193125-26-237195
- form_type: 8-K
- ticker: JAGX
- cik: 0001585608
- company_name: Jaguar Health, Inc.
- filed_at: 2026-05-22T21:22:44+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1585608/000119312526237195/0001193125-26-237195-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1585608/000119312526237195/d138181d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-237195
- JSON: https://secwatch.observer/filing/0001193125-26-237195.json
- Plain text: https://secwatch.observer/filing/0001193125-26-237195.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.